T. Fujita et al., Immunosuppressive effect on T cell activation by interleukin-16-cDNA-transfected human squamous cell line, CELL IMMUN, 202(1), 2000, pp. 54-60
It is well known that it is difficult to induce an immunotolerance with all
ogeneic skin transplantation. We attempted to find the immunosuppressive pr
otocol for prolonging skin allograft rejection by using interleukin-16 beca
use IL-16 is considered one of the natural ligands to CD4 molecules. First
we examined whether synergistic immunosuppressive effects of recombinant IL
-16 plus anti-CD4 mAbs are induced in mixed lymphocyte reaction (MLR). Next
we used IL-16-cDNA-transfected OSC-20 (human oral squamous cell carcinoma
cell line) as an in vitro model of the epidermal keratinocyte equivalent an
d examined whether this transfectant could inhibit the activation of alloge
neic T cells. Our data indicated that IL-16 clearly inhibited human MLR and
that IL-16 increased synergistically the immunosuppressive effect of anti-
CD4 mAb. We also used IL-16 transfectant and this produced more than 50 ng/
ml of IL-16 in the supernatant by which human MLR was significantly inhibit
ed. Furthermore, this transfectant also inhibited the activation of allogen
eic lymphocytes stimulated directly with transfectant cells. These results
indicated that the IL-16-producing allogeneic skin graft might have a local
immunosuppressive action that would prolong graft survival. (C) 2000 Acade
mic Press.